In this work, we showed that nasally administered immunobiotics were able to improve respiratory Th1 response since significantly higher levels of IFN-γ were found in the respiratory tract of lactobacilli-treated mice.
Modulation of respiratory immunity potentiated by the immunobiotic strains might contribute to an improved Th1 response and thereby favor protective immunity against viral infections such as RSV.